Safety, Tolerability and Immunogenicity of a Plant-Made H1 VLP Influenza Vaccine in Adults
Phase of Trial: Phase I
Latest Information Update: 15 Aug 2013
At a glance
- Drugs Influenza A virus vaccine-H1N1 (Primary) ; Influenza virus vaccine
- Indications Influenza A virus H1N1 subtype; Influenza virus infections
- Focus Adverse reactions; Pharmacodynamics
- 12 Sep 2011 Results presented at the Fourth ESWI Influenza Conference, according to a Medicago media release.
- 08 Jun 2011 Secondary endpoints 'Geometric-mean-antibody-titre' and 'Immunological-response-rate' have been met.
- 06 Jun 2011 Status changed from recruiting to active, no longer recruiting, as reported by ClinicalTrials.gov.